InvestSMART

Lumos Diagnostics Holdings Limited (ASX: LDX) - Announcements

Current share price for LDX : $0.105 0.005 (4.55%)+

ASX company news and announcements for Lumos Diagnostics Holdings Limited (LDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Lumos Diagnostics Holdings Limited (LDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Lumos Diagnostics Holdings Limited (LDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Lumos Diagnostics Holdings Limited (LDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$99 Application for quotation of securities - LDX 5 Jul 2023 6:26PM $0.086 $0.105 risen by 22.09%
$99 Application for quotation of securities - LDX 4 Jul 2023 5:01PM $0.155 $0.105 fallen by 32.26%
$99 Lumos Receives US FDA Clearance for FebriDx 3 Jul 2023 9:23AM $0.011 $0.105 risen by 854.55%
$99 Change in substantial holding 9 Jun 2023 11:17AM $0.014 $0.105 risen by 650%
$99 Application for quotation of securities - LDX 6 Jun 2023 4:57PM $0.017 $0.105 risen by 536.36%
$99 Change in substantial holding from RYD 6 Jun 2023 4:32PM $0.017 $0.105 risen by 536.36%
$99 Change in substantial holding 6 Jun 2023 9:59AM $0.015 $0.105 risen by 600%
$99 Application for quotation of securities - LDX 2 Jun 2023 2:55PM $0.014 $0.105 risen by 650%
$99 Change in substantial holding 18 May 2023 11:57AM $0.017 $0.105 risen by 517.65%
$99 Notification regarding unquoted securities - LDX 10 May 2023 4:04PM $0.019 $0.105 risen by 452.63%
$99 Change in substantial holding 10 May 2023 10:32AM $0.019 $0.105 risen by 452.63%
$99 Change in substantial holding 10 May 2023 10:28AM $0.019 $0.105 risen by 452.63%
$99 Application for quotation of securities - LDX 4 May 2023 4:59PM $0.023 $0.105 risen by 356.52%
$99 Application for quotation of securities - LDX 4 May 2023 9:20AM $0.030 $0.105 risen by 250%
$99 Change in substantial holding 28 Apr 2023 5:09PM $0.018 $0.105 risen by 483.33%
$99 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2023 9:50AM $0.017 $0.105 risen by 517.65%
$99 Change in substantial holding 14 Apr 2023 3:26PM $0.023 $0.105 risen by 356.52%
$99 Notification of cessation of securities - LDX 13 Apr 2023 12:57PM $0.023 $0.105 risen by 356.52%
$99 Application for quotation of securities - LDX 13 Apr 2023 12:53PM $0.023 $0.105 risen by 356.52%
$99 Application for quotation of securities - LDX 5 Apr 2023 11:54AM $0.025 $0.105 risen by 320%
$99 Change in substantial holding 4 Apr 2023 2:35PM $0.025 $0.105 risen by 320%
$99 Change in substantial holding from RYD 30 Mar 2023 4:35PM $0.027 $0.105 risen by 288.89%
$99 Application for quotation of securities - LDX 17 Mar 2023 4:39PM $0.031 $0.105 risen by 238.71%
$99 Lumos to present at NWR Virtual Healthcare Conference 17 Mar 2023 4:33PM $0.031 $0.105 risen by 238.71%
$99 Lumos signs three new agreements with Hologic 16 Mar 2023 9:08AM $0.031 $0.105 risen by 238.71%

326 - 350 of 544 results

Page 14 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.